Our advisory board.

Prof. Jörg Steinbach, renowned expert in the field of radiochemistry and radiopharmacy, former director of the Radiopharmaceutical Institute at the Helmholtz-Zentrum Dresden-Rossendorf, specialized in the development of innovative (PET) radiotracers, active for many years in renowned scientific societies and committees.

Sven Jezoreck held various management positions in Deutsche Bank's Corporate Clients division for over 30 years (most recently as Head of Corporate Clients Germany until 2020) and today mainly advises medium-sized companies as a partner in a corporate finance advisory firm.

Rudolph Lüning, a well-known entrepreneur with exceptional expertise in medical technology, founded numerous innovative companies, helped Keradenta to a new lease of life in the 1990s and founded Ascalon, Alpha Plan and others.

Rico Schulze, pharmacist, supervised sterile and patient-specific drug production, headed the official expert group “Radiopharmaceuticals” for many years, has been working on drug and health issues in the Saxon Ministry of Social Affairs since 2019, publishes articles in “pharmind” - where he is also a member of the advisory board - and gives lectures on GxP-related topics.

Dr. Helmut Wolf, a chemist and process engineer with a passion for the development and production of sterile pharmaceuticals, has held important international positions up to CEO including a dynamic leadership position at Lyocontract, today a recognized freelance consultant for sterile formulations.